MANAGEMENT
We are governed and supervised by a five-person board of directors. Our day-to-day operations are managed by the Company’s officers.
Board of Directors
The Company’s Board of Directors consists of the following members:
|
Frank Gerardi
|
Chairman
|
|
Robert C. Hackney
|
Director
|
|
John Fanaras
|
Director
|
|
Richard P. Tambone
|
Director
|
|
Tipton Shonkwiler
|
Director
|
NOTE: For Full bio on Board of Director Members, see Appendix
Corporate Management
|
Frank Gerardi
|
Interim Chief Executive Officer
|
|
Richard P. Tambone
|
Chief Financial Officer
|
|
John Fanaras
|
Chief Operating Officer
|
|
Robert C. Hackney
|
Secretary
|
Scientific Advisor
David J. Vaughan acts as an advisor to the Company. Dr. Vaughan holds a Ph.D. in Clinical Pathology and Biochemistry from the University of Toronto as well as an M.Sc. in Biochemistry and a B. Sc. In Chemistry from Memorial University of Newfoundland. Dr. David Vaughan is currently active as an independent consultant to the Pharmaceutical Industry with significant clinical / preclinical development and regulatory expertise in the Anti-infectives, Pain, CNS, and Gastrointestinal Disease areas. Dr. Vaughan has guided and successfully completed preclinical development programs for several biotechnology companies resulting in multiple IND and CTA approvals. Dr. Vaughan has a lengthy Curriculum Vitae and has worked in the pharmaceutical industry for over thirty years.
